U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H32F3N3O4
Molecular Weight 495.5345
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SILODOSIN

SMILES

C[C@H](CC1=CC(C(N)=O)=C2N(CCCO)CCC2=C1)NCCOC3=CC=CC=C3OCC(F)(F)F

InChI

InChIKey=PNCPYILNMDWPEY-QGZVFWFLSA-N
InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
SILODOSIN
DASH   EMA EPAR   INN   JAN   MART.   MI   ORANGE BOOK   VANDF   WHO-DD  
INN  
Official Name English
RAPAFLO
Brand Name English
SILODOSIN [ORANGE BOOK]
Common Name English
KSO-0400
Common Name English
URIEF
Brand Name English
SILODOSIN [EMA EPAR]
Common Name English
(-)-1-(3-HYDROXYPROPYL)-5-((2R)-2-((2-(2-(2,2,2-TRIFLUOROETHOXY)PHENOXY)ETHYL)AMINO)PROPYL)-2,3-DIHYDRO-1H-INDOLE-7-CARBOXAMIDE
Systematic Name English
2,3-DIHYDRO-1-(3-HYDROXYPROPYL)-5-((2R)-2-((2-(2-(2,2,2-TRIFLUOROETHOXY)PHENOXY)ETHYL)AMINO)PROPYL)-1H-INDOLE-7-CARBOXAMIDE
Systematic Name English
KAD-3213
Code English
SILODOSIN [JAN]
Common Name English
silodosin [INN]
Common Name English
SILODOSIN [MI]
Common Name English
SILODYX
Brand Name English
RAPILIF
Brand Name English
SILODOSIN [VANDF]
Common Name English
Silodosin [WHO-DD]
Common Name English
KMD-3213
Code English
SILODAL
Brand Name English
SILODOSIN [MART.]
Common Name English
UROREC
Brand Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS UROREC (AUTHORIZED: PROSTATIC HYPERPLASIA)
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
NDF-RT N0000175553
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
WHO-ATC G04CA04
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
LIVERTOX NBK548170
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
NCI_THESAURUS C29713
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
NDF-RT N0000000099
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
EMA ASSESSMENT REPORTS SILODYX (AUTHORIZED: PROSTATIC HYPERPLASIA)
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
WHO-VATC QG04CA04
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
Code System Code Type Description
SMS_ID
100000090781
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
EPA CompTox
DTXSID40167045
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
DRUG CENTRAL
4151
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
INN
8043
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
DRUG BANK
DB06207
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
CAS
160970-54-7
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
DAILYMED
CUZ39LUY82
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
RXCUI
720825
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY RxNorm
MERCK INDEX
m9912
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY Merck Index
WIKIPEDIA
SILODOSIN
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
NCI_THESAURUS
C81372
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
EVMPD
SUB23152
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
FDA UNII
CUZ39LUY82
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
ChEMBL
CHEMBL24778
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
IUPHAR
493
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
PUBCHEM
5312125
Created by admin on Fri Dec 15 15:49:12 UTC 2023 , Edited by admin on Fri Dec 15 15:49:12 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of SILODOSIN
METABOLITE (PARENT)
Structure of KDM-3289
METABOLITE (PARENT)
Structure of KDM-3295
METABOLITE (PARENT)
Structure of KMD-3241
METABOLITE ACTIVE (PRODRUG)
Structure of KMD-3241G
METABOLITE LESS ACTIVE (PARENT)
Structure of KMD-3213G
METABOLITE LESS ACTIVE (PARENT)
Structure of KMD-3293
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966